Navigation Links
Registration Open for WBBA's Life Science Innovation Northwest 2011 Event Webcast
Date:2/16/2011

SEATTLE, Feb. 16, 2011 /PRNewswire/ -- Register for the webcast now: www.onetotheworld.net/lsinw2011Event: Life Science Innovation Northwest 2011 http://www.washbio.org/displaycommon.cfm?an=1&subarticlenbr=145When: March 2-3, 2011Where: Washington State Convention Center http://www.wsctc.com/Event Detail: http://www.washbio.org/associations/11076/files/LSINW%20Fact%20Sheet%202011.pdfLive Event Registration Information: https://m360.washbio.org/event.aspx?eventID=22551Understand the Webcast Technology: www.onetotheworld.comOne to the World™ (OttW) is pleased to open online registration for the webcast of Life Science Innovation Northwest (LSINW), the region's premier life sciences conference, hosted by the Washington Biotechnology & Biomedical Association (WBBA) and Burrill & Company. Hailing speakers from around the world – this event has never been more global or globally broadcast.

OttW technologists are delivering a dynamic webcast featuring preeminent speakers and LSINW's entire event. LSINW has confirmed prominent Keynote Speakers, James C. Greenwood, President and CEO of the Biotechnology Industry Organization (BIO) in Washington, D.C., and G. Steven Burrill, Founder and CEO of Burrill & Company. OttW's content delivery system enables a far richer visual experience including; high resolution graphics and multiple data streams (video, PowerPoint, Q&A/polling) to run simultaneously. Event programs include:

  1. Partnering to Drive Innovation
  2. Life Sciences in the Pacific Northwest: Creating the Future
  3. Global solutions, Local benefit
  4. Lessons Learned:  How to Position your Company for Success

These preeminent programs highlight the growth and innovation in the Pacific Northwest's life science sector and features medical technology, diagnostics, and therapeutic innovations, as well as cutting-edge scientific and educational developments in global health. Using OttW's polling feature and SuperChat™ viewers can live chat and provide on-the-spot feedback from seats in Seattle and Asia, India, Australia, Scandinavia, and Germany.

Through sponsorship of the live webcast, Global Health Nexus (GHN) http://globalhealthnexus.org/ further cements their leading position of enhancing connection and collaboration between the business and research communities. GHN wealth of expertise and resources support life science innovations throughout the year both regionally and globally.

"At Global Health Nexus we are proud to partner with OttW in delivering this premier broadcast. At OttW we are leading the curve of change in event, training and education communications. It's happening now in the Pacific Northwest - this hub of energy and progress being made in Life Sciences will affect lives throughout the world. This progress belongs to everyone."  ~ John Vadino Founder One to the World™

About One to the World (formerly Dynamic Webcasting) - http://www.onetotheworld.com


'/>"/>
SOURCE One to the World
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Pittsburgh-based BIOSAFE Receives EPA Registration and Enters Into Commercialization Agreement with Union Springs Pharmaceuticals
2. BioMed Realty Trust Announces Planned Filing of Resale Registration Statement in Connection With 3.75% Exchangeable Senior Notes Due 2030
3. LS9's UltraClean Diesel™ Receives EPA Registration
4. invivodata Opens Registration for 3rd Annual Patient Reported Outcomes Conference
5. Dempsey Challenge Participant Registration Officially Open
6. 3SBio Inc. Applies for SFDA Registrational Trial for Feraheme(TM)
7. AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma
8. Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM)
9. Cellu Tissue Holdings, Inc. Files Registration Statement for Proposed Initial Public Offering of Common Stock
10. United States Securities and Exchange Commission Declares Effective Registration Statement for NeoStems Acquisition of China Biopharmaceuticals Holdings, Inc. and a Controlling Interest in Leading Chinese Pharmaceutical Company; Meeting of Each Com
11. PTC Therapeutics Initiates Registration-Directed Phase 3 Trial of Ataluren in Cystic Fibrosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... February 27, 2017 Four US ... evaluation today, and they are: Anthera Pharmaceuticals Inc. (NASDAQ: ... California Inc. (NASDAQ: PACB), and Conatus Pharmaceuticals Inc. (NASDAQ: ... ETF Trends, market observers are growing more bullish on ... enact reforms to free cash held overseas for tax ...
(Date:2/26/2017)... ... ... Rob Lowe is a well recognized television personality, so it seems natural he would ... important to the American public and important to society at large. An upcoming episode ... the world for a few years. , The climate and how we relate to ...
(Date:2/24/2017)... KNOXVILLE, Tenn. , Feb. 24, 2017 /PRNewswire/ ... ) ("Provectus" or the "Company"), a clinical-stage oncology ... information regarding the deadline to participate in its ... million units, consisting of shares of common stock ... stockholders and holders of listed warrants. ...
(Date:2/24/2017)... Staten Island, NY (PRWEB) , ... February 24, 2017 , ... ... exponential rate. Founded in late 2014, FireflySci had the goal of bringing their ... 2017, that goal continues to shape the path that FireflySci is going on as ...
Breaking Biology Technology:
(Date:2/7/2017)... MINNETONKA, Minn. , Feb. 7, 2017   ... that supports the entire spectrum of clinical research, is ... iMedNet , its innovative, highly flexible and ... iMedNet customers. iMedNet is a ... only provides Electronic Data Capture (EDC), but also delivers ...
(Date:2/6/2017)... According to Acuity Market Intelligence, ongoing ... to continue to embrace biometric and digital identification ... Border Control (ABC) eGates and 1436 Automated Passport ... 163 ports of entry across the globe. Deployments ... combined CAGR of 37%. APC Kiosks reached 75% ...
(Date:2/2/2017)... 2, 2017   TapImmune, Inc. (NASDAQ: ... specializing in the development of innovative peptide and ... cancer and metastatic disease, announced today it has ... of a second clinical lot of TPIV 200, ... alpha. The manufactured vaccine product will be used ...
Breaking Biology News(10 mins):